LANCE RICHARD BRUCK, MD, FACOG, FACS Chairman Hugh K. Miller, MD Department of Obstetrics and Gynecology Stamford Health System EDUCATION: 1985-1989 Muhlenberg College Allentown, PA Bachelors of Science (Biology and Philosophy) Magna Cum Laude 1989-1993 New York Medical College Valhalla, NY Medical Degree POST-GRADUATE TRAINING: 1993-1996 Resident, Obstetrics and Gynecology Albert Einstein College of Medicine Montefiore Medical Center Jacobi Medical Center Bronx, NY 1995 Galloway Fellowship, Gynecologic Oncology Memorial Sloan-Kettering Cancer Center New York, NY 1996-1997 Chief Resident, Obstetrics and Gynecology Albert Einstein College of Medicine Montefiore Medical Center Jacobi Medical Center Bronx, NY PROFESSIONAL EMPLOYMENT: 1996-1998 Obstetric and Gynecologic Consultant Planned Parenthood of Nassau County 1997 Attending Physician - Jacobi Medical Center Private Practice Attending Physician – Larchmont, NY Riker’s Island High Risk Obstetric Consultant – Queens, NY Montefiore Medical Center 1997-2005 Medical Director of Women’s Health Services Jacobi Medical Center / North Bronx Healthcare Network lbruck Page 1 2/15/2016 1998-2007 Director of Gynecology Jacobi Medical Center / North Bronx Healthcare Network 2005-2007 Director of Gynecologic and Reproductive Health Research Jacobi Medical Center / North Bronx Healthcare Network 2006-2007 Vice Chairman Department of Obstetrics, Gynecology and Women’s Health North Bronx Healthcare Network 2007-present Chairman Department of Obstetrics and Gynecology Stamford Health System HOSPITAL APPOINTMENTS: 1997-2008 North Bronx Healthcare Network Jacobi Medical Center North Central Bronx Hospital 1997-2008 Montefiore Medical Center 2007-present Stamford Health System ACADEMIC APPOINTMENTS: 1997-2000 Instructor: Obstetrics, Gynecology and Women’s Health Albert Einstein College of Medicine 2000-2006 Assistant Professor: Obstetrics, Gynecology and Women’s Health Albert Einstein College of Medicine 2001-2007 Site Director: Female Pelvic Medicine and Reconstructive Surgery Fellowship Program Albert Einstein College of Medicine 2006-present Associate Professor: Obstetrics, Gynecology and Women’s Health Albert Einstein College of Medicine Fellowship Director: Gynecologic Endoscopy Affiliated with the AAGL and SRS Jacobi Medical Center North Bronx Healthcare Network 2007 BOARD CERTIFICATION: lbruck Page 2 2/15/2016 July 1994 Diplomate of the National Board of Medical Examiners November 1999 Diplomate of the American Board of Obstetrics and Gynecology PROFESSIONAL SOCIETY MEMBERSHIP: Fellow of the American College of Obstetricians and Gynecologists Fellow of the American College of Surgeons American Urogynecologic Society American Society for Colposcopy and Cervical Pathology American Association of Gynecologic Laparoscopists Association of Professors of Gynecology and Obstetrics Society of Laparoendoscopic Surgeons American College of Physician Executives Bronx Gynecological and Obstetrical Society Physicians for Reproductive Choice and Health Alumni Association of New York Medical College The Martin L. Stone Obstetrical and Gynecological Society AWARDS AND HONORS: 1989 Lindback Scholarship for Academic Excellence and Community Service Muhlenberg College 1992 Schueuer Family Foundation Scholarship New York Medical College OTHER PROFESSIONAL ACTIVITIES: 1997-2007 New York Medical Alliance, PC Member of the Board of Directors 2002-2007 New York Medical Alliance, PC Corporate Officer lbruck Page 3 2/15/2016 2002-present Peer Journal Reviewer Obstetrics and Gynecology 2002-2007 Affinity Health Plan Credentialing and Medical Peer Review Committee 2003-present Rockshelter Consulting, PC President 2004-present American Cystoscope Manufacturers, Inc. Medical Advisory Board 2005-2007 Faculty Editor Einstein Journal of Biology and Medicine 2005-present Gyrus Medical, Inc. Medical Advisory Board 2005-present Peer Journal Reviewer The American Journal of Managed Care 2006-present Board of Observers Muhlenberg College 2007-present Stamford OB/GYN Associates, PC President 2007-present Fairfield County OB/GYN, LLC President ALBERT EINSTEIN COLLEGE OF MEDICINE COMMITTEES 1997-2007 Departmental Committee for Resident Training 1997-2007 Ambulatory OB/GYN Elective Leader 1999-2007 Dean’s Letter Committee for Medical Students 2001-2007 Committee of Admissions 2002-2005 Department of Education Education and Faculty Support Committee 2004-2005 Faculty Senate 2006-2007 Ad hoc Promotion Chair GRANT SUPPORT: A randomized, double-blind, placebo-controlled, parallel-group, multicenter, 12-week lbruck Page 4 2/15/2016 study assessing the effects of femhrt on vasomotor symptoms in postmenopausal women of minority ethnic groups. Protocol#: A4111002. Sponsor: Pfizer. Sub-investigator. $42,062 Comprehensive Family Planning and Reproductive Health Care Services Grant (2002-2009) New York State Department of Health. Principal Investigator. $592,429/annum A multicenter, phase III, double-blind, placebo-controlled, parallel study of ADL 8-2698 in opioid induced postoperative bowel dysfunction/postoperative ileus. Protocol #: 14CL308. Sponsor: Adolor Corporation. Principal investigator. $102,293 Multi-center, double blind, randomized, placebo-controlled, multiple dose study of the analgesic efficacy and safety of acetaminophen injection 1g vs. placebo for pain following vaginal hysterectomy. Protocol # 136-03-03. Sponsor: Bristol-Meyers-Squibb. Principal investigator. $36,510 SGN-00101 (HspE7) immunotherapy of CIN III. Protocol # 5850. Sponsor: CTEP/NIH/Stresgen. Sub-investigator. $15,000 A double-blind, randomized, controlled phase III study to assess the prophylactic efficacy and safety of gD Alum/MPL vaccine in the prevention of genital herpes disease in young women who are HSV-1 and –2 seronegative. Protocol # 208141/039. Sponsor: NIH/GlaxoSmithKline. Principal investigator. $1,835,740 A double-blind, randomized, controlled study to evaluate the immunogenicity and safety of GlaxoSmithKline biologicals herpes simplex candidate vaccine (gD2-AS04) in healthy HSV seronegative and seropositive female subjects aged 10-17 years. Protocol # 208141/040. Sponsor: GlaxoSmithKline. Sub-investigator. $ 73,800 An international, randomized, double-blind, placebo-controlled, multicenter, 6-month study of the efficacy and safety of valaciclovir 1g once daily vs. placebo for the suppression of HSV-2 genital herpes in newly infected immunocompetent subjects. Protocol # HS2100275. Sponsor: GlaxoSmithKline. Principal investigator. $24,552 An open-label study of the efficacy and safety of 5 and 10 mg Vesicare (solifenacin succinate) in patients with overactive bladder (OAB) symptoms. Protocol # 905-UC-007. Sponsor: Yamanouchi Pharma America, Inc.. Principal Investigator. $19,500 Identification of genetic susceptibility loci in women with cervical cancer. Protocol # K12 RR017672. Sponsor: NIH/NCRR. Sub-investigator. $145,173/annum (2003-2007) A randomized, double-blind, placebo-controlled, multi-center, two-way crossover study to investigate the effect of Valtrex 1g once daily for 60 days on viral shedding in HSV-2 lbruck Page 5 2/15/2016 seropositive subjects with no previous history of symptomatic genital herpes infection. Protocol # VLX103596. Sponsor: GlaxoSmithKline. Principal Investigator. $27,790 A 12-week, randomized, open-label, parallel-group, multicenter study to evaluate the efficacy, safety and tolerability of Enablex (darifenacin) (with voluntary up-titration from 7.5mg o.d. to 15mg o.d. at week 2) alone or in combination with behavioral modification for symptoms of overactive bladder. Protocol # CAR328AUS01. Sponsor: Novartis Pharmaceuticals. Principal Investigator. $30,551 A randomized, placebo-controlled phase II study of multiple dosing regimens of intravaginally administered 851B gel for the treatment of cervical high risk HPV infection. Protocol # 1547-851B. Sponsor: 3M pharmaceuticals. Principal Investigator. $ 129,611 A phase II, randomized, double-blind, placebo-controlled, trial of the use of 4,4 – dinitrophenyl-hydrazone (A-007) topical gel in the treatment of high-grade squamous intraepithelial lesions (HSIL) of the cervix. Protocol TG-001B. Sponsor: Tigris Pharmaceuticals. Principal Investigator. $ 66,195 A multi-center prospective clinical study to evaluate the performance and clinical predictive value of the Invader® HPV HR Molecular Assay and Invader® HPV 16 / 18 Molecular Assay for the detection of Human Papillomavirus in cervical cytology samples. Protocol # DP0517. Sponsor: Third Wave Technologies, Inc. Principal Investigator. $87,656 A Phase III Randomized, Double-Blind, Placebo-Controlled, Multi-Center, ParallelGroup, Single- and Multiple-Dose Study of the Analgesic Efficacy and Safety of Intravenous Acetaminophen (IV APAP) Versus Placebo Over 48 Hours for the Treatment of Postoperative Pain after a Total Abdominal Hysterectomy. Protocol # CPI-APA-301. Sponsor: Cadence Pharmaceuticals, Inc.Principal Investigator. $90,000 A phase IIIb, subject- and observer-blind, randomized, multicenter study with two parallel groups to compare the immunogenicity of GlaxoSmithKline Biological’s HPV16/18 L1/AS04 vaccine versus Merck’s Gardasil® vaccine when administered intramuscularly according to a 3-dose schedule in healthy adult females 18-45 years of age. Protocol # 108993/010. Sponsor: GSK Biologicals. Principal Investigator. $80,000 INVITED PRESENTATIONS: Critical review of the routine postoperative fever evaluation on a gynecologic surgery service. American College of Obstetricians and Gynecologists, 1998 Junior Fellow Annual Meeting lbruck Page 6 2/15/2016 Management of ectopic pregnancy. North Bronx Healthcare Network. Bronx, NY. Pediatric Emergency Medicine Grand Rounds. January 1999. Evaluation and management of urinary incontinence. North Bronx Healthcare Network. Bronx, NY. Internal Medicine Grand Rounds. February 2000. A review of single dose methotrexate for the treatment of ectopic pregnancy. Health and Hospitals Corporation 2001 Board Meeting Management of surgical abortion complications. New Insights into Family Planning and Abortion: Enhancing your Gynecologic Practice, 2002 Family Planning Update – New York City Health and Hospital Corporation Detection of cervical human papillomavirus infection by in-situ hybridization in fetuses of women with squamous intraepithelial lesions. The American Society for Colposcopy and Cervical Pathology, 2004 Biennial Meeting Update on sexually transmitted infections. Bayshore Community Hospital. Holmdel, NJ. Grand Rounds. July 2005. The future of OB/GYN as a career path. Muhlenberg College. Allentown, PA. Invited alumnus lecturer. November 2005. Laparoscopic supracervical hysterectomy. Englewood Hospital. Englewood, NJ. Grand Rounds. January 2006. Management of adnexal masses. North Bronx Healthcare Network. Bronx, NY. Emergency Medicine Grand Rounds. April 2006. Cervical dysplasia prevention: HPV vaccination. Bronx Lebanon Hospital. Bronx, NY. Grand Rounds. February 2007. HPV vaccines: the new era in HPV management. Saint Vincent’s Medical CenterManhattan. New York, NY. Grand Rounds. April 2007. HPV and the new vaccine era. Stamford Hospital. Stamford, CT. Grand Rounds. May 2007. Management of Chronic Pelvic Pain. Cablevision - 12 on Health. November 2007 Hope for the Mid-life Female. Fairfield County Parish Nurse Grand Rounds. Stamford, CT. May 2008. Chronic Pelvic Pain – Causes and Treatments. GE Women’s Stay Healthy Lecture Series. Stamford, CT. July 2008. lbruck Page 7 2/15/2016 COURSE DIRECTOR: New Insights into Family Planning and Abortion: Enhancing your Gynecologic Practice, 2002 Family Planning Update – New York City Health and Hospital Corporation. Bronx, NY. New Technologies in Minimally Invasive Surgery. 2008 Annual Obstetric and Gynecology Symposium – Stamford Health System. Stamford, CT. BIBLIOGRAPHY: Original Communications in Reviewed Journals: Bruck LR, Sherer DM. Intrapartum sonography of the lower uterine segment in patients with breech-presenting fetuses. American Journal of Perinatology 1997;14:315-6. Cole DS, Bruck LR. Anaphylaxis after laminaria insertion. Obstetrics and Gynecology 2000;95:1025. Lazarou G, Powers K, Pena C, Bruck L, Mikhail M. Inflammatory reaction following bovine pericardium graft-augmentation for posterior vaginal wall defect repair. International Urogynecology Journal and Pelvic Floor Dysfunction 2005;16:242-244. Bruck LR, Zee S, Poulos B, Abadi M. Detection of cervical human papillomavirus infection by in situ hybridization in fetuses of women with squamous intraepithelial lesions. Journal of Lower Genital Tract Disease 2005;9:114-117. Bruck LR, Lazarou G, Mussalli G, Bobby P. Surgical reconstruction of congenital hypertrophy of the perineal body. Journal of Pelvic Medicine and Surgery 2006;12:219223. Lazarou G, Powers K, Pena C, Bruck L, Mikhail M. Inflammatory response to bovine pericardium: reply to letter by Davila. International Urogynecology Journal and Pelvic Floor Dysfunction 2006; 17:551. Abstracts: Anderson PS, Smith HO, DeVictoria C, Hurde C, Fields AL, Bruck LR, Runowicz CD, Goldberg GL. The potential role of preoperative CA19-9 in patients with endometrial cancer. ACOG 1995 Annual Meeting. San Francisco, CA. Bruck LR, Cole D, Goldberg GL. Critical review of the routine postoperative fever evaluation on a gynecologic surgery service. ACOG 1998 Junior Fellow Annual Meeting. New York, NY. Simon BJ, Valentine N, Bruck LR. A retrospective chart review of single dose methotrexate for the treatment of ectopic pregnancy at Jacobi Medical Center from 1998lbruck Page 8 2/15/2016 2001. 3rd World Congress on Controversies in Obstetrics, Gynecology and Infertility. Washington, DC. Ng E, Damus K, Bruck LR, MacIsaac L. Advance provision of levonorgesterol-only emergency contraception versus prescription. ACOG 2003 annual meeting. New Orleans, LA. Bruck LR, Zee SY, Poulos BK, Carroll DA, Abadi M. Detection of cervical human papillomavirus infection by in-situ hybridization in fetuses of women with squamous intraepithelial lesions. The American Society for Colposcopy and Cervical Pathology 2004 Biennial Meeting. Orlando, FL. Abadi MA, Kra J, Bruck LR. Detection of HPV in fetal larynx. 24th International HPV Meeting. Beijing, China. Development of a bladeless tissue morcellator using plasma kinetic technology. Anderson TL, Bruck LR, Lyons TL Advincula AP. 36th Global Congress of Minimally Invasive Gynecology. Washington, DC. lbruck Page 9 2/15/2016